Navigation Links
Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide
Date:1/9/2008

ffiliated institutions where he rose to the rank of Professor of Medicine. He has written more than 100 peer- reviewed articles on the treatment of diabetes and has been recognized both locally and nationally for his research in diabetes and growth factors.

Moses received a Bachelor of Science from Duke University and a Medical Doctorate from Washington University School of Medicine prior to training at Barnes Hospital in St. Louis, the National Institutes of Health in Bethesda, Md., and Tufts-New England Medical Center in Boston. He is board certified by the American Board of Internal Medicine and has a subspecialty certification in Endocrinology and Metabolism.

About Novo Nordisk

Novo Nordisk is a healthcare company with an 84-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 25,800 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
2. Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
3. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Ikaria Appoints Daniel Tasse as President and Chief Executive Officer
6. SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer
7. Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors
8. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
9. Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
10. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
11. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., SCHIEDLBERG, Austria, November 9 /PRNewswi... the world have been working on the development of...t communication channel,between the brain and a co...,patients to communicate or to control devices in ...the last years some patients have been supervised ...
(Date:11/9/2009)... Product release is a resea...ubjects, research facilities and research safety s...n. , Cedar Knolls, NJ (PR...nounced today that it has unveiled Pristima™...r research facilities that track the use and care ...
(Date:11/6/2009)..., TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Micro...y that it has re-filed the Form 52-109F1 Certifica...f Executive Officer and James Long, the Chief Fina... January 12, 2009 in connection with the annual au...ember 30, 2008. ,, The Company initially filed ...
(Date:11/6/2009)..., SAN MATEO, Calif., Nov. 6 /PRNewswire-FirstCal... Completed transfer of Qutenza(TM) E.U. Marketing ...e significant progress in commercial readiness act...les; Senior Director, Marketing; and Director, Com...to board as director and Audit Committee chairman ...
Breaking Biology Technology:intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10
...y of grant-winning ability, the University of Wis... National Science Foundation to address some of t...change. , ,The NSF grants, coupled with matching i...ost to the university,s graduate study and researc...onmental protection. , ,The two $3 million grants...
...ng of new products, or simply the last rush to get...ay was a busy day for product news. In fact, two D...tive newcomer Streamload - are delivering signif...s. , ,In the case of Palm, it is the Treo 700p sma...based on a lovely new implementation of the Palm O...
...holder lawsuits alleging violations of federal sec...nologies, Inc. has accepted the resignation of co...rtimore, who founded the company and served as its...en appointed as the company,s interim CEO. Mike Du... named chairman of the board of directors, succeed...
Other Biology Technology:NSF grants bolster integrative graduate study at UW-Madison 2Two DEMO alumni make big product splashes 2Two DEMO alumni make big product splashes 3Merge president steps down in wake of shareholder suits 2Merge president steps down in wake of shareholder suits 3
(Date:11/6/2009)...A (November 06, 2009) The Monell Center and the C...he Beijing International Meeting on Taste and Smel...ith the CAS, the meeting will be the first interna...ina. , Alan Leshner, Chief Executive Officer, Am...and Executive Publisher of Science magazine, will ...
(Date:11/5/2009)...Conn.Researchers at Yale University have developed...,s immune response to HIV and HIV-infected cells, ...s, published online in the Journal of the America...ic approaches for these diseases. , The molecul... HIV" (ARM-H) and "antibody-recruiting molecule ta...
(Date:11/4/2009)...A Although scientists are reluctant to officially...evidence continues to grow about its protective ef...in Cancer Prevention Research , a journal of the ...ggests some reduction in oral cancer. , Vassili... in the Department of Thoracic/Head and Neck Medic...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2SpectraScience Engages European Contract Research Organization to Manage Clinical Trials 14457 1SpectraScience Engages European Contract Research Organization to Manage Clinical Trials 14457 2SpectraScience Engages European Contract Research Organization to Manage Clinical Trials 14457 3Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 1Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 2Amylin Pharmaceuticals to Webcast Third Quarter Results 14453 1Amylin Pharmaceuticals to Webcast Third Quarter Results 14453 2
...dy, researchers present a “cautionary tale?about w...of proteomics to devise a diagnostic test for canc...the National Cancer Institute, researchers from Th... detail why an experimental test intended to ident...ood is unlikely to lead to a reliable clinical tes...
...dy, researchers present a “cautionary tale?about w...of proteomics to devise a diagnostic test for canc...the National Cancer Institute, researchers from Th... detail why an experimental test intended to ident...ood is unlikely to lead to a reliable clinical tes...
... Today, Affymetrix, Inc.,announced plans to make e...s available in 2005 as part of its Consortia Progr...ncatula (legume), Brassica, tomato,citrus, poplar...ns at,this week,s Plant and Animal Genome Conferen...rays launched in 2004 under the Consortia,Program....
Other Biology News:Signaling protein builds bigger, better bones in mice 2Signaling protein builds bigger, better bones in mice 3Cracking the olfactory code in bees 2Cracking the olfactory code in bees 3Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering 2
...ion: 0.15M NaCl, 20mM MOPS, pH 7.5, 60mM 2-mercapt...perites: For selective in vitro dephosphorylation ...alent cation activation plus trypsin digestion, an... routinely evaluated by dephosphorylation of prote...
Anti-Human sVCAM-1 / CD106 ELI-PAIR Kit Antibody, Unconjugated from Cell Sciences
Mouse Anti-GLP-1 Monoclonal Antibody, Unconjugated, Clone HYB 147-12 from Santa Cruz Biotechnology, Inc.
21-mer duplex design + syn.; 1 gene from B-Bridge International
Biology Products: